MedTrace Logo

Three Dimensional Ultrasonographic Detection of Human Ovulation

NCT06433453 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-05-29

No results posted yet for this study

Summary

The research aims to compare diagnosis of ovulation and anovulation in 2D and 3D ultrasonography.

Conditions

  • Ovulation Disorder

Interventions

DRUG

Indomethacin 50 MG

The medication is commenced when a preovulatory follicle is observed. It will be administered for a minimum of one day, up to a maximum of 7 days. It will be discontinued when anovulation is observed.

PROCEDURE

Transvaginal ultrasound scans

Ultrasound scans done intermittently before and after an ovulatory or anovulatory event

DIAGNOSTIC_TEST

Finger prick blood test

Capillary blood extracted from a finger prick. Blood spots are collected on a specialized card, dried and frozen before reproductive hormones are assayed from them.

DIAGNOSTIC_TEST

Urine test

Early morning urine tests to assay reproductive hormones

Sponsors & Collaborators

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Angela R Baerwald, PhD,MD,CCFP · University of Saskatchewan

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-22
Primary Completion
2024-12-31
Completion
2025-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06433453 on ClinicalTrials.gov